Drugs / Live double combined lactobacillus capsule
Live double combined lactobacillus capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07418996 | May 2021 → Jul 2022 | bacterial vaginosis | Guangdong Longchuangji Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live double combined lactobacillus capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07418996 ↗ |
| Modality | Other / unclassified | “a dual live bacteria formulation” NCT07418996 ↗ |